Form 8-K - Current report:
SEC Accession No. 0001437749-24-022162
Filing Date
2024-07-03
Accepted
2024-07-03 15:07:33
Documents
15
Period of Report
2024-07-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plse20240702_8k.htm   iXBRL 8-K 29076
2 EXHIBIT 99.1 ex_695236.htm EX-99.1 14811
  Complete submission text file 0001437749-24-022162.txt   180754

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plse-20240703.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plse-20240703_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE plse-20240703_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plse-20240703_pre.xml EX-101.PRE 11583
17 EXTRACTED XBRL INSTANCE DOCUMENT plse20240702_8k_htm.xml XML 2825
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 241099754
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)